Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients-authors' response
Lanzhou Univ, Sch Nursing, Evidence Based Nursing Ctr, Lanzhou, Gansu, Peoples R China
;
Lanzhou Univ, Dept Intens Care Unit, Hosp 1, Lanzhou, Gansu, Peoples R China
